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Traumatic brain injury (TBI) is a major health concern in industrialised countries.  Sleep and 
wake disturbances are among the most persistent and disabling sequelae after TBI. Yet, 
despite the widespread complaints of post-TBI sleep and wake disturbances, studies on their 
etiology, pathophysiology, and treatments remain inconclusive. This narrative review aims to 
summarise the current state of knowledge regarding the nature of sleep and wake disturbances 
following TBI, both subjective and objective, spanning all levels of severity and phases post-
injury. A second goal is to outline the various causes of post-TBI sleep-wake disturbances. 
Globally, although sleep-wake complaints are reported in all studies and across all levels of 
severity, consensus regarding the objective nature of these disturbances is not unanimous and 
varies widely across studies. In order to optimize recovery in TBI survivors, further studies are 
required to shed light on the complexity and heterogeneity of post-TBI sleep and wake 
disturbances, and to fully grasp the best timing and approach for intervention.  





Traumatic brain injury (TBI) is the leading cause of mortality and invalidity among 
young adults in industrialized countries, with an incidence estimated at over 600 per 100 000 
individuals [1,2]. This high incidence represents a major public health concern since TBI often 
results in long-term physical, cognitive and psychological sequelae that interfere with general 
functioning and return to work or school.  
Sleep-wake disturbances, particularly fatigue, insomnia and hypersomnia, are among 
the most prevalent and persistent sequelea reported after TBI [3,4]. They have been 
consistently reported among TBI survivors across all levels of severity, from the acute stage to 
several years post-injury [5-7]. Yet, the pathophysiology of post-traumatic sleep-wake 
disturbances is still poorly understood. 
The purpose of this narrative review is to describe and appraise the current state of 
knowledge regarding sleep-wake disturbances following TBI across all levels of severities, 
spanning the continuum of recovery from the acute stage (first weeks post-injury) to the 
chronic stage, including years post-injury. A second goal is also to describe the possible 
causes of sleep-wake disturbances following TBI, as well as pharmacologic and non-
pharmacologic treatment options for the management of sleep-wake disturbances post-injury. 
Finally, the importance of sleep for cognitive and functional recovery will be discussed, and 
general directions for future study perspectives will be provided.  
For the purpose of this literature review, the acute phase of TBI refers to the first 6 
months post-injury, which constitutes the period immediately following TBI and the early 
phase of recovery. The chronic phase of TBI will refer to the period following the acute phase, 
spanning from 6 months to several years post-injury, regardless of the presence of symptoms. 
2. Diagnosis and general consequences of TBI 
Traumatic brain injury occurs when an external force causes an alteration in brain 
functions such as decreased level of consciousness, loss of memory, neurological deficits or 
any alteration in mental state at the time of the injury [8]. The diagnosis of TBI necessarily 
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involves a severity assessment [9]. Globally, mild TBI (mTBI) is characterized by a short loss 
of consciousness (< 30 min), and/or a short post-traumatic amnesia (< 24 h), a Glasgow Coma 
Scale (GCS) score [10] between 13 and 15 [1]. Sports-related brain injuries with an alteration 
in mental state are generally referred to as “concussion”. Moderate and severe TBI are 
typically associated with longer loss of consciousness, a GCS score equal or lower than 12, 
and PTA longer than 24 h. No hospital admission is generally required for mTBI, while 
moderate and severe TBI often necessitate hospitalisation in the intensive care unit due to the 
presence of cerebral haemorrhages, contusions and intracranial hypertension [11].  
The most frequent causes of TBI are motor-vehicle accidents, falls, assault, 
recreational and sport-related injuries, and work accidents [12,13]. The principal factors 
known to increase the risk of sustaining a TBI are age (15-24 years old) and gender (male); 
other factors are alcohol or drug addiction, low socioeconomic status, and low education [14].  
The extent of functional and cognitive deficits observed in the acute period is highly 
variable among TBI patients and depends on several factors, such as location of focal lesions 
[15,16], severity of diffuse axonal injury, length of PTA [15,17], age[16, 18], education [16], 
and preexisting conditions [19]. Despite the variability of deficits, they can be categorized in 
relation to their influence on cognition, social behaviors, psychological status, and somatic 
symptoms. 
In fact, arousal and alertness impairments, reduced information processing speed, 
impaired memory, executive dysfunctions, impaired communication, and reduced self-
awareness are among the most frequent cognitive deficits observed [20]. Neurobehavioral 
impairments such as impulsivity, irritability, disinhibition, mutism, confusion and 
confabulatory communication, and apathy can be observed, particularly in those with more 
severe injuries and or in the acute stage of injury [21]. Psychological sequelae, such as 
irritability, anxiety, and depressed mood can be observed in ≥50% of individuals in the first 6 
months following severe TBI [22]. These affective symptoms remain prevalent among 16-
48% of patients over the two years post-injury, and are reported at many years post injury 
(>10yrs) in those with chronic sleep-wake disorders [23]. Finally, somatic symptoms, such as 
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headache, dizziness, but also perturbation in sleep are often reported in the hours following 
TBI [22] and these symptoms remain present in 23-65% of patients two years after TBI onset.  
Recovery from symptoms usually takes place within 1 to 3 months in mTBI, while 
85% of the improvement in functioning occurs in the first six months and improvement 
continues until one year after moderate to severe TBI [24]. Unfortunately, impairments in 
these symptoms, including in those related to sleep disturbances, persist over one year in 50% 
of moderate-severe TBI patients [25], affecting their autonomy, productivity, and their quality 
of life [26].  
3. Sleep disturbances following TBI 
3.1. Changes in sleep quality and quantity 
Complaints of sleep loss and poor sleep quality are common following TBI. These 
comprise complaints of difficulties initiating and maintaining sleep, frequent arousals, and 
early awakenings. In the following section, prevalence of poor sleep quality and related 
polysomnographic findings will be described for mTBI and for the moderate-severe TBI 
population separately. For each TBI severity population, results for the acute and chronic 
phases will be reported. 
3.1.1. Acute stage of mTBI 
 According to Chaput et al. [27], sleep complaints are present in the first days and 
weeks following mTBI. In fact, 13.3% of the 443 patients included in their study reported 
sleep complaints on the Rivermead post-concussion symptom assessment questionnaire 10 
days post-injury, while this proportion increased to 33.5% at 6 weeks post-injury. 
Interestingly, patients with sleep complaints at 10 days post-injury were 2.9 times more likely 
to experience sleep difficulties at 6 weeks post-injury and were more likely to suffer from 
irritability, depressive symptoms, and headaches at both 10 days and 6 weeks post-injury, 
suggesting that acute sleep complaints predict psychological and somatic symptoms among 
individuals with mTBI. Poor sleep quality was also reported after sports-related concussions 
where athletes who had suffered at least one concussion (4.4±3.8 months since injury) 
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complained of worst sleep quality, more severe sleep disturbances and poorer daytime 
functioning on the Pittsburgh Sleep Quality Index when compared with healthy control 
athletes [28].  
Although a high proportion of patients have sleep complaints in the acute phase of their 
mTBI, heterogeneous results were obtained on objective measures of sleep such as 
polysomnography (PSG). In fact, several authors found no differences in sleep 
macroarchitecture between mTBI patients and controls in the acute stage of the injury [28-30].  
Conversely, studies looking at sleep microarchitecture have found promising results. In 
fact, Rao et al. [29] showed that mTBI patients within 1 week of injury had abnormalities in 
sleep EEG power spectral analyses when compared to matched controls. More specifically, 
mTBI patients had lower delta power, but higher alpha and beta power in non-rapid eye 
movement (NREM) sleep.  A more recent study conducted by Khoury et al. [31] compared 24 
mTBI patients (45 ± 22.7 days post-injury) with post-traumatic sleep complaints to 18 controls 
on quantitative EEG during sleep. Overall, results showed that patients reported a worse sleep 
quality for their in-laboratory sleep recording compared with control subjects. Moreover, 
mTBI patients had significantly longer sleep latency (17.8 ± 15.3 min vs. 8.9 ± 5.7 min), 
which was within normal range (<20 min) despite their complaints of poor sleep, and lower 
sleep efficiency (89.2 ± 7.5% vs. 93.7 ± 5.7%). Lower delta in REM sleep and higher beta and 
gamma power in NREM sleep were also observed among the mTBI group compared to the 
control group, and pain was the main factor associated with abnormal EEG power during 
sleep. This microarchitecture sleep pattern characterised by reduced power of low frequency 
bands and increased power of high frequency bands may represent hyperarousal among mTBI 
individuals and was previously documented among insomniac patients [32].  
3.1.2. Chronic stage of mTBI 
Subjective sleep complaints have also been widely documented in long-term mTBI, the 
most pervasive of which are insomnia, sleep fragmentation, and early morning awakenings. 
[3,33,34] Beetar et al. [33] conducted a retrospective chart review in order to compare the 
incidence of sleep complaints in symptomatic mTBI. The study included 202 TBI patients 
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(127 mild and 75 moderate-severe) 23.9 ± 21.2 months post-injury, who were compared to a 
group of non-TBI neurologic patients. Insomnia complaints were reported by 65.3% of all 
mTBI patients. Overall, insomnia complaints were significantly more prevalent in the TBI 
group compared with the non-TBI neurologic patients (56.4% vs. 30.9%), and more frequent 
among mTBI than moderate-severe TBI (65.4% vs. 41.3%). Sleep complaints were still 
present in 23.7% of mTBI patients at least five years post-injury. In another study aiming to 
delineate which factors predict suboptimal outcome after TBI, Clinchot et al. [34] found that 
approximately 75% of the 145 mTBI patients included in their study reported sleep 
disturbances one year post-injury, the most common of which was waking up too early. 
Globally, these studies indicate that complaints of poor sleep are found in approximately 65-
75% of chronic mTBI patients. 
With the conflicts in Afghanistan and Iraq, the military population has recently sparked 
the interest of TBI researchers, even though the mechanism of injury often differs from that of 
TBI in civilians. One study [35] evaluated 116 soldiers with combat-related blunt and blast 
TBI (84.5% mild) 16.1 ± 11.5 months post-injury using directed questioning regarding sleep 
complaints. Nearly all (97.4%) participants reported sleep complaints. More specifically, poor 
sleep quality was reported by 81.9% of participants, and 54.3% reported sleep fragmentation. 
According to the study by Bryan [36], the incidence of insomnia increased with TBI frequency 
in the military population, from 5.6% for no TBIs, 20.4% for single TBI, and 50.0% for 
multiple TBIs.  
In the chronic phase of mTBI, studies that have objectively measured sleep through 
PSG have generally been able to corroborate the pervasive self-reported complaints of 
disturbed sleep identified in the abovementioned studies. More specifically, studies using PSG 
have shown that those with mTBI and persistent symptoms have less efficient sleep, shorter 
REM onset latency, longer sleep onset latency, shorter total sleep time, a decrease in REM 
sleep and an increase in stage N2 sleep, when compared to healthy age- and sex-matched 
controls [37,38]. In the abovementioned study performed among soldiers [35], PSG findings 
revealed sleep fragmentation, with an average sleep efficiency of 86.3% ± 12.1% and a mean 
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total arousal index of 17.7± 11.5 events per hour. Insomnia was present in 55.2% of their 
subjects based on DSM-IV diagnostic criteria.  
Importantly however, to our knowledge, there have not been any studies to date that 
have objectively investigated the sleep of all those with mTBI; current studies are limited to 
recruitment of participants with self-reported sleep complaints. Such a study would be 
invaluable in order to elucidate on the role of mTBI in generating structural sleep changes, and 
on the factors associated with the presence and absence of sleep complaints.  
3.1.3. Acute stage of moderate and severe TBI 
Clinical observations in acute care settings suggest that sleep disturbances appear in the 
first weeks after TBI, where patients present insomnia, an inability to stay awake for a few 
consecutive hours during the day, and/or altered sleep-wake cycles.  To date, a few studies 
have investigated acute sleep-wake disturbances during the period of hospitalisation, including 
in the intensive care unit (ICU), regular units of trauma center and in rehabilitation centers 
during the early period of rehabilitation.  A recent study conducted by our group aimed to 
measure the rest-activity cycle when patients were hospitalised in the intensive care unit and 
regular wards, looking specifically at the consolidation of rest and activity periods, or patients’ 
ability to sustain activity during the day and rest during the night [39]. Using 10-day 
actigraphy recordings in 16 TBI patients, the study showed severe fragmentation of the rest-
activity cycle, reflecting fragmentation of sleep and wake episodes. Using a ratio of daytime 
activity to 24h activity ≥80% to denote rest-activity cycle consolidation, we were able to show 
that the rest-activity cycle was consolidated only 46.6% of all days, but that a significant linear 
trend of improvement was found over time. Worse sleep-wake cycle consolidation and 
evolution were associated with higher TBI severity, and longer duration of ICU and hospital 
stay. Patients with more rapid return to a consolidated rest-activity cycle were more likely to 
emerge from PTA and to have lower disability at hospital discharge. Another preliminary 
study conducted by our group compared the sleep architecture of 6 moderate-severe TBI (4 
males; 25±11.3 yrs) during their hospital stay to that of 11 healthy controls (7 males; 25±10.5 
yrs) [40]. The TBI patients underwent 24-h bedside ambulatory PSG, while controls 
underwent in-laboratory PSG. Our results indicated that TBI patients had more fragmented 
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sleep characterised by greater total wake duration, (159±104.7 min on average as compared to 
53.7±47.0 for controls) and a higher number of arousals (49.7±35.4 on average as compared to 
20.2±7.8 for control subjects).  Sleep efficiency for those with TBI was 74±15.9% (on 
average) in comparison to 88±9.3% for controls. 
Studies carried out during early rehabilitation also point to a high prevalence of sleep-
wake disturbances. One research group conducted a prospective observational study of 31 
patients with moderate-severe TBI admitted to an inpatient rehabilitation unit, and found that 
68% had disturbed nighttime sleep, defined as two or more hours awake during the night, as 
measured by hourly nurse observations [41]. This same group conducted another study in 
which they used actigraphy on 14 moderate-severe TBI patients for the duration of their stay 
in a rehabilitation unit, between 9 to 23 days post-injury [42]. Overall, 78% of patients had a 
mean 1-week sleep efficiency that was severely impaired (≤ 63%). Patients who had cleared 
PTA prior to rehabilitation admission had significantly better sleep efficiency than patients 
with ongoing PTA. Nakase-Richardson et al. [43] conducted a prospective observational study 
on primarily severe TBI patients, using item one of the Delirium Rating Scale-Revised-98 
(DelRS-R98) to classify the severity of sleep-wake cycle disturbance as none, mild, moderate, 
or severe. Results showed that mild to severe sleep disturbances were present among 84% of 
patients upon admission to a rehabilitation hospital, and persisted for 66% of patients one 
month post-injury. The presence of sleep disturbance at one month post-injury had a 
significant predictive value on the duration of PTA.  
3.1.4. Chronic Moderate-Severe TBI 
Studies investigating subjective sleep complaints in the chronic phase of moderate-
severe TBI patients point to frequent complaints of TBI-induced changes in sleep quality 
[3,34,44-48], changes in bedtime[47,48], longer sleep onset latency [46-48], more nocturnal 
awakenings [47], and symptoms of insomnia [3,49]. Overall, subjectively-reported sleep 
changes have been reported in 42 to 80% of TBI patients, though perception of one’s 
condition may be altered by persistent cognitive deficits among this population, leading to and 
underreporting of complaints [34,45-48]. In a meta-analysis of 1706 TBI survivors 
documented across 21 studies utilizing both objective and self-report measures, Mathias and 
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Alvaro [50] reported that TBI survivors were likely to suffer from insomnia (observed in 50% 
of TBI patients), difficulty maintaining sleep (50%), poor sleep efficiency (49%), early 
morning awakenings (38%), difficulty with sleep initiation (36%) and nightmares (27%).   
Studies that have used PSG to objectively measure sleep in chronic moderate-severe 
TBI patients have shown impaired sleep efficiency [44,51], an increase in slow wave sleep 
[52], and excessive nocturnal awakenings [51,53]. Interestingly, Mathias and Alvaro [2012] 
reported that objective sleep measures identified more sleep-wake problems than self-report 
measures on problems with sleep maintenance, sleep efficiency, and awakening [50].  
Ouellet et al. [3] used a detailed questionnaire to assess the sleep quality and fatigue of 
452 community-based TBI patients (all severity; 83.2% moderate-severe). Over 50% of 
patients reported symptoms of insomnia, and 29.4% fulfilled the diagnostic criteria for an 
insomnia syndrome. In a cross-sectional study including 121 TBI survivors 2 years post-
injury, Cantor et al. [49] found a similar prevalence of insomnia syndrome (24%) using the 
DSM-IV and ICSD diagnostic criteria. Since these patients were not recruited from a sleep 
clinic or according to the presence of sleep complaints, these results suggest that a high 
proportion of TBI patients have sleep problems but do not consult a sleep clinic, leaving these 
problems untreated.  
Although studies that have utilized objective sleep measures have also identified 
various sleep disturbances in moderate-severe TBI patients, one study reported no significant 
differences on PSG variables between 22 moderate and severe TBI survivors tested 53.0 ± 
37.1 months post-injury compared to 22 controls [54]. However, patients in this particular 
study were community-based participants who were not consulting a sleep clinic, as opposed 
to most other PSG studies on moderate-severe TBI patients. Because time since injury ranged 
from 1 to 11 years, the authors suggested that objectively-measured sleep alterations could 
become gradually attenuated over time, which could explain why their study showed no 
significant differences between TBI patients and controls. Another study sought to compare 
subjective sleep complaints to objective measures in 14 TBI patients 21 months post-injury on 
average with an insomnia complaint and 14 healthy controls [53]. Even though significant 
differences were found on all subjective sleep measures, no PSG variables were significantly 
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different between groups. These findings highlight an important issue for consideration when 
comparing research across the literature, as some studies recruit on the basis of self-report of 
sleep problems, or those seeking help for sleep problems, while others, such as the study by 
Beaulieu-Bonneau [54], do not. 
3.2. Hypersomnia and excessive daytime sleepiness 
Hypersomnia, or increased sleep need per 24-h, is a widespread condition following 
TBI that is often associated with excessive daytime sleepiness (EDS), though EDS may be a 
result of insomnia or poor nocturnal sleep. One study group has suggested that pleiosomnia, or 
an increased need for sleep of at least 2 hours per 24-h, was a more accurate term to reflect an 
increased pressure to sleep following TBI [52]. In the following section, hypersomnia and 
EDS are presented for mild and moderate-severe TBI separately.  
3.2.1. Mild TBI 
Watson et al. [55] used the Sickness Impact Profile, a detailed health status 
questionnaire that measures behavioral changes due to illness, to assess sleepiness at one 
month post-injury, for which they evaluated 348 TBI patients (78% mild TBI), 132 non-
cranial trauma controls, and 102 trauma-fee controls. The study showed that at one month 
post-injury, a significantly greater proportion of TBI subjects (55%) endorsed one or more 
sleepiness items of this questionnaire, as opposed to non-cranial trauma controls (41%) and 
trauma-free controls (3%). A greater number of TBI subjects endorsed each of the four 
sleepiness items than did both control groups. Among the military population, complaints of 
EDS were identified as being widely pervasive, and reported by 85.2% of participants [35]. 
Despite this high prevalence of daytime sleepiness, very few studies investigated 
hypersomnia and EDS using objective measures among the mTBI population. One study used 
the Multiple Sleep Latency Test (MSLT) to compare the sleepiness mTBI patients (12 months 
to 21 years post-injury) who had been referred to a sleep lab to that of healthy matched 
controls. The MSLT tests for excessive daytime sleepiness by measuring sleep latency during 
five scheduled daytime naps, each separated by two hours of wake. The authors were able to 
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confirm patients’ complaints and showed that mTBI patients had significantly greater number 
of sleep entrance episodes, and a significantly shorter time to fall asleep [38]. 
Gosselin et al. [28] examined the spectral analysis of the waking EEG in 11 concussed 
athletes as compared to healthy control athletes. Their results showed increased delta and 
reduced alpha EEG activity during wakefulness, while no modifications were found during 
sleep despite the high frequency of poor sleep quality complaints, suggesting that sport-related 
concussions are associated with wakefulness dysfunctions rather than sleep disturbances per 
se. The authors proposed that this waking EEG pattern may represent impaired vigilance 
among concussed athletes. 
3.2.2. Moderate-severe TBI 
Studies carried out one to three months post-injury have shown that daytime sleepiness 
is highly present following moderate-severe TBI [55,56].  While Watson et al. [55] found that 
greater sleepiness was associated with greater TBI severity, Rao et al. found no such 
association [56]. Studies investigating subjective daytime complaints in the chronic phase of 
moderate-severe TBI patients point to more frequent and longer daytime napping [48,54,57], 
and EDS [30,48,51,57,58].  
Among studies that have recruited patients with sleep complaints, the study conducted 
by Verma et al. [51] showed that 30 of the 60 TBI patients (60% moderate-severe according to 
the Global Assessment of Functioning scale) reported hypersomnia as their presenting 
complaint. Overall, 28 patients had an elevated Epworth Sleepiness Scale (ESS) score higher 
than 11, pointing to EDS. Of these 28 participants who underwent MSLT, 15 had a mean sleep 
onset latency <5 min, confirming their complaints. Sommerauer et al. [52] conducted a case-
control study compared 36 consecutively admitted TBI patients (13 mild; 23 moderate-severe) 
who reported pleiosomnia, defined as an increase need for sleep of at least 2h per 24h, to 
healthy controls, using detailed history, sleep logs, actigraphy, nocturnal PSG, and the MSLT. 
They found that EDS was highly prevalent (42%), as was the number of patients taking 
daytime naps (47%). The authors also found that nocturnal total sleep time was increased in 
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TBI patients, though patients underestimated their need for sleep. This finding led the authors 
to conclude that pleiosomnia may be even more frequent than previously reported.  
Other studies that have recruited their TBI patients from the community, without 
considering the presence of sleep complaints, and yet have also found daytime sleepiness 
[4,30]. Baumann et al. [30], who evaluated 65 patients 6 months post-injury, and Castriotta et 
al. [4], who evaluated 87 TBI patients (8% mild; 59% moderate-severe; remaining TBI of 
unknown severity) 64.3 ±117.7 months post-injury, both used PSG, and MSLT to assess 
objective sleepiness in TBI patients. In their studies Baumann et al. [30] and Castriotta et al. 
[4], found that hypersomnia was present in 25 and 11%, respectively.  Using a criteria of sleep 
latency <5 min on the MSLT to represent EDS, Baumann et al. [30] also showed that 25% of 
the study sample had objective EDS, compared to 1-6% in the general population [59]. This 
prevalence of objective daytime sleepiness was close to that of subjective daytime sleepiness, 
as measured by the ESS, which was found in 28% of the sample. Twelve patients (18%) 
reported regular daytime napping (≥3 per week). Though Baumann et al. [30] found that 
hypersomnia was associated with severe TBI, Castriotta et al. [4] found no association 
between daytime sleepiness and injury severity or time since injury.    
Despite several studies having highlighted the increase in EDS following TBI, the 
previously mentioned study by Beaulieu-Bonneau [54] revealed no significant differences on 
objective sleepiness, as measured by MSLT, between 22 moderate and severe TBI survivors 
tested 53.0 ± 37.1 months post-injury and 22 matched controls.  
4. Other sleep-wake disorders common following TBI 
Overall, studies that have objectively measured sleep using PSG have also found other 
sleep disorders in chronic moderate-severe TBI. Among them, the study by Verma et al. [51], 
included 60 TBI patients (40% mild, 60% moderate-severe; 3 months to 2 years post-injury) 
consulting in a sleep clinic and the following sleep disorders have been observed: hypoxia 
(observed in 70% of patients), periodic leg movement during sleep (35%), REM sleep 
behaviour disorder or increased electromyogram tone during REM sleep (13%), and sleep-
onset REM periods, often associated to narcolepsy (5.5%).  Parasomnia were diagnosed in 16 
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patients (25%) and comprised acting out dreams (8%), sleepwalking (8%), nightmares (7%), 
sleep paralysis (5%), nocturnal enuresis (5%), cataplexy (3%) and nocturnal eating (3%) [51]. 
Other studies have recruited their TBI patients in community, without considering the 
presence of sleep complaints, have also shown that several sleep disorders were present 
following TBI. When using PSG among those TBI patients (all severity) 64.3 ±117.7 months 
post-injury, Castriotta et al. [4] found abnormal sleep in 46% of the study sample, which 
included obstructive sleep apnea (OSA) (23%), hypersomnia (11%), periodic leg movements 
in sleep (7%), and narcolepsy (6%). Among soldiers with TBI, 34.5% had OSA syndrome 
[35]. 
4. Pathophysiology of sleep-wake disturbances following TBI  
The pathophysiology of post-traumatic sleep-wake disturbances still remains unclear 
but can possibly be explained by a complex interaction between several physiological, 
environment, and psychological factors.  
4.1. Brain lesions and brain dysfunctions 
Abnormal neuroimaging results, mostly from computed tomography scanning, are 
found in approximately 5 to 10% of mTBI patients [22] and in up to 90% of patients with 
severe TBI [60]. Traumatic brain injury also results in more subtle brain damage characterised 
by decreased synaptic density, and axonal and dendritic degeneration [61]. The cortical and 
subcortical structures and networks involved in sleep, wake, and circadian rhythmicity may be 
impaired or damaged in a proportion of TBI patients and possibly explain part of the sleep-
wake disturbances observed in this population, but no study specifically assessed this 
association yet. 
Baumann [30] found that in 43% of his study sample, potential causes of sleep and 
wake disturbances could not be explained by any other factor than the TBI itself (all severity). 
The possible factors that were considered were sleep-related breathing or movement disorders, 
narcolepsy or behaviourally induced insufficiency sleep syndrome, substance abuse, 
demographic characteristics, residual clinical symptoms, or other TBI characteristics.  
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Furthermore, it has been shown that patients in the acute phase of moderate to severe TBI 
have abnormally low levels of hypocretin-1 levels in their cerebrospinal fluid [30,62]. 
Hypocretin-1 (orexin A) is an excitatory neuropeptide produced by the hypothalamus, which 
is involved in the regulation of arousal.  Involvement of the hypocretin system in the acute 
sleep-wake disturbances of TBI patients is possible, and could be linked to hypersomnia. 
However, based on currently available research, the hypocretin system may not necessarily 
explain the high prevalence of chronic sleep-wake disturbances, including insomnia as return 
to normal values of hypocretin has been observed 6 months post-TBI. Further research is 
needed to elucidate the underlying pathophysiological mechanisms of chronic sleep-wake 
disturbances of varying diagnoses (i.e. insomnia, hypersomnia, fragmented sleep, increased 
sleep need, pleiosomnia).  
4.2. Circadian rhythm disturbances  
One factor that may contribute to sleep-wake disturbances is altered circadian rhythms. 
The circadian clock, located in the suprachiasmatic nucleus of the hypothalamus, is primarily 
synchronised to the 24-h environmental day by the light-dark cycle [63,64]. Circadian 
disruption occurs when the main biological clock, located in the hypothalamus, is not 
synchronised to the 24-h day and/or when it produces a circadian signal too weak to entrain 
properly the peripheral clocks located in other regions of the brain and body. One of the most 
obvious manifestations of circadian disruption is a decreased consolidation and abnormal 
timing of the sleep-wake cycle [65]. 
Sleep-wake disturbances reported by mTBI patients in the chronic phase of injury may 
be caused by circadian rhythm dysfunctions that can be manifested as advanced or delayed 
phase syndrome. Concordant with this hypothesis, Ayalon et al. [66] used actigraphy, salivary 
melatonin, oral temperature measurement and PSG, to evaluate 42 patients with mTBI and 
insomnia. The authors founds that 15 (36%) had circadian rhythm sleep disorders (8 had a 
delayed sleep phase syndrome and 7 displayed an irregular sleep–wake pattern).  
Alterations in daily rhythms have also been found in chronic moderate and severe TBI, 
where patients showed decreased evening melatonin production [44,67]. Decreased melatonin 
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secretion, however, was not found in another study performed in 10 TBI patients 516 ± 124.04 
days post-injury and 10 age- and sex-matched controls [68].  
Moreover, the immune response triggered by the TBI itself, and possibly other injuries 
that may accompany it, could contribute to circadian dysregulation following injury. Indeed, 
increasing evidence points to a bidirectional communication between circadian physiology and 
immune function [69]. 
Clock genes may also be dysregulated following TBI. An animal study conducted by 
Boone et al. [70] found that male rats exposed to fluid-percussion TBI had altered circadian 
gene expression in both the suprachiasmatic nucleus (SCN) and hippocampus, when compared 
to sham surgery rats. Bmal1 and Cry1, both key clock genes, were dysregulated, as was the 
daily rhythm of locomotor activity, which persistently showed reduced activity in the TBI 
group, coinciding with the dysregulation of clock genes in the SCN and hippocampus. The 
authors suggested that a disturbance in the transcriptional-translation feedback loops that 
modulate circadian timing could be induced by TBI. 
During the hospitalisation period following TBI, the hospital environment itself may 
favour the loss of light/dark circadian cues due to constant lighting [71], which can influence 
the circadian clock. The fact that patients are bedridden in a constant horizontal posture may 
also promote daytime sleep, which in turn, also influences nocturnal sleep. A few studies have 
investigated the circadian rhythms of acute TBI patients hospitalised in the intensive care unit, 
all of which have pointed to major circadian anomalies, which suggest that brain injury may 
aggravate circadian rhythms disturbances found among critically ill patients [72-74]. A 
prospective clinical study conducted by Paul and Lemmer [72] showed an absence of 24-h 
variation in well-documented markers of circadian rhythms, namely body temperature, 
plasmatic melatonin and cortisol, heart rate, blood pressure, and spontaneous motor activity in 
24 critically ill analgo-sedated patients. The observed circadian rhythm disturbances were 
more pronounced in the 11 patients with severe brain injury (including 3 moderate-severe TBI 
patients, 7 patients with subarachnoid hemorrhage following the rupture of an intracerebral 
aneurysm, and 1 patient with hypoxic brain injury) than in patients without a brain injury. To 
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our knowledge, no study has specifically sought out to investigate circadian alterations in the 
acute phase of mTBI. 
4.3. Endocrine dysfunction 
Endocrine dysfunctions are also common following TBI, especially for endocrine 
functions emerging from the pituitary, and reported as varying from 15% to as high as 90% 
among moderate-severe TBI patients 2 weeks to several years post-injury [75,76]. These 
disturbances include hypopituitarism, impaired growth hormone release, 
hypo/hyperthyroidism, hypothalamic gonadism, and abnormal adrenocortical function. 
Endrocrine disturbances may be associated with sleep-wake disturbances and fatigue 
following TBI, as some endocrine changes, such as growth hormone (GH) deficiency and 
altered cortisol levels, are known to have specific effects on sleep architecture. To test for 
endocrine dysfunctions, routine blood tests can be carried out to assess hormone levels of the 
pituitary gland, particularly those of the anterior pituitary (e.g. somatotrophins, corticotropins, 
thyrotrophins, lactotrophins and gonadotropins), most commonly found to be altered following 
TBI (see Table 1). 
4.4. Impact of the hospital environment 
In the acute phase post-injury, hospitalised TBI patients are confronted by 
environmental conditions that are unfavourable to adequate sleep and circadian rhythmicity. 
Many factors may account for the poor sleep of hospitalised patients, particularly in the ICU 
environment, where several sources of noise are present, including alarms and conversations 
from healthcare personnel [77]. In fact, Friese et al. [78] indicated that 36% of hospitalised 
TBI patients with sleep complaints pointed out the hospital environment as an important 
causal factor. Receiving 24-hour care has also been shown to make sleep more difficult [79]. 
Being under the effects of sedatives, analgesics, narcotics, anticonvulsants and antipsychotics 
may also influence sleep characteristics [80]. As previously mentioned, the loss of light-dark 
circadian cues due to constant lighting may also be an environmental factor highly responsible 
for sleep-wake and circadian disturbances.  
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4.5. Anxiety and depression 
Anxiety and depression have been shown to be highly prevalent after TBI and to have 
a negative impact on sleep [3,23,46,47,67]. Furthermore, those with TBI can suffer from acute 
post-traumatic stress disorder, a mental disorder that can manifest itself following a 
psychologically traumatizing event, and can lead to an alteration of sleep and a decrease of 
slow-wave sleep [81]. Huang et al. [45] recently examined risk factors associated with 
persistent sleep complaints following TBI (all severity).  The authors subdivided the 25 
patients with persistent sleep complaints into two groups, comparing those with sleep 
complaints at 6 and 12 months to those with complaints at 12 months only. The group with 
complaints at 6 and 12 months had higher levels of depression and post-traumatic distress at 
both 6- and 12-months post-injury. Conversely, Rao et al. [56] reported that based on 
structured clinical interview, the presence of insomnia in the acute period following TBI was 
related to heightened anxiety. With regards to TBI, depression has been associated with 
reports of sleep changes and worse sleep quality, as well as an increase in nighttime 
awakenings (subjective and objective) [47,31]. Though anxiety and depression can alter sleep 
and wake, these studies do not suggest that sleep-wake disturbances are only driven by these 
effects, but that they may rather occur in parallel.  
4.6. Pain 
Pain is another factor to which sleep disturbances have been partly attributed in several 
studies [3,31,33,46,48,67,82]. In fact, Beetar et al. [33] showed that when patients with pain 
complaints were removed from his study sample, the prevalence of insomnia complaints was 
reduced by nearly half, plummeting from 69% to 38.6%. A recent study linked pain with an 
increase in rapid EEG frequency bands mostly during REM and slow wave sleep in mTBI (45 
± 22.7 days post-injury) with pain [31]. TBI patients without pain did not exhibit rapid EEG 





5. Management of sleep-wake disturbances  
5.1. Modifying the hospital and early rehabilitation environments to improve sleep  
Since the environment may increase sleep disturbances in the hospital setting, some 
environmental factors may be easily modified to promote sleep. For example, providing 
patients with ear plugs and eye masks, or minimizing staff interventions at night and during 
naps could enable patients to have a more restorative sleep [77].  
Among individuals with circadian disorders (i.e. phase advance or delay), light therapy 
has been shown to adjust the circadian clock to the environment [83], and has been recognized 
by the American Academy of Sleep Medicine [84]. Light therapy has previously been used 
among in the ICU among non-TBI patients, and has been shown not only to improve patients’ 
circadian rhythms, and lead to a swifter recovery [85], but the efficiency of this intervention 
needs to be evaluated among acute TBI patients.  
5.2. Interventions to improve insomnia 
Prior to treating insomnia, the clinician should screen for other sleep disorders (e.g. 
restless leg syndrome) as well as medical (e.g. acute and chronic pain) or psychiatric 
conditions (e.g. anxiety, depression, and posttraumatic stress disorder) that may be associated 
with, or underlie insomnia (see Table 1). 
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Table 1. Screening and interventions for post-TBI insomnia and hypersomnia (list not 
exhaustive).  
 Insomnia Hypersomnia 
SCREENING Insomnia and hypersomnia may be caused or exacerbated by the following conditions, 
which should be ruled out. 
Medical history A particular attention should be paid to: 
- Acute/chronic pain 
- Current (or withdrawal from) 
medication and dosage  
 
A particular attention should be paid to: 
- Neurodegenerative diseases 
- Current medication and 
dosage 
- Weight gain 




- Acute/chronic stress 
- Depression (and other mood 
disorders) 
- Posttraumatic stress disorder 
- Substance abuse disorders 
- Depression (and other mood 
disorders) 
- Substance abuse disorders 
Sleep disorders - Restless leg syndrome 
- Sleep breathing disorders (apnea, 
sleep maintenance insomnia) 
- Circadian rhythm disorders (phase 
advance or delay) 
- Sleep breathing disorders 
(apnea) 
- Narcolepsy 
- Kleine-Levine syndrome 
- Behaviorally induced 
insufficient sleep syndrome 
- Circadian rhythm disorders 
(phase advance or delay) 
Blood tests - Endocrine (pituitary) function 
o Somatotrophins (growth hormone (GH))  
o Corticotropins (adrenocorticotropic hormone (ACTH), beta-
endorphin) 
o Thyrotrophins (thyroid-stimulating hormone (TSH))  
o Lactotrophins (prolactin (PRL)) 
o Gonadotropins  (luteinizing hormone (LH), follicle-stimulating 
hormone (FSH)) 
INTERVENTIONS If sleep-wake disturbances are associated to another psychiatric or medical condition, 
this condition should also be treated. 
Modifications of the 
hospital environment 
- Ear plugs 
- Eye mask 
- Minimizing staff interventions during nighttime/naps 
- Light therapy or exposure to natural light in the morning (hypersomnia) 
Non-pharmacological - Sleep hygiene 
o Regular bed/wake times 
o Avoiding lengthy daytime naps (more than 60 minutes) 
o Avoiding daytime naps after 3:00 PM 
o Avoiding coffee and alcohol 4 to 6 hours prior to bedtime 
o Avoiding strenuous exercise at least one hour prior to bedtime 
o Avoiding stimulant activities at least one hour prior to bedtime (video 
games, suspense movies) 
o Avoiding nicotine in the hours prior to bedtime or during awakenings 
in the night 
o Avoiding light and noise in the bedroom during the night 
o Using the bed only for sleep or sexual activities 
o Going to bed only when ready to sleep  
- Light therapy in the morning (hypersomnia) 
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- Cognitive behavioral therapy (insomnia) 














Prescription and over-the-counter pharmacologic interventions are the most common and 
accessible treatments for insomnia. However, although pharmacologic interventions have been 
effective in treating sleep disturbances in healthy individuals, it has been consistently reported 
that benzodiazepines, the most frequently prescribed sleep agent used to treat insomnia, and 
GABA-agonists result in cognitive impairment when plasma levels are at their peak [86]. There 
also exists some evidence suggesting that benzodiazepines produce residual effects on cognition, 
whereas some have shown the GABA agonists may have detrimental effects on neuroplasticity 
[86]. Moreover, the side-effects of sedative-hypnotic sleep-agents, such as the Z-drugs, include 
daytime drowsiness, as well as cognitive and psychomotor impairments, all of which are likely to 
add to the burden of TBI sequelea [87].  
Conversely, the use of oral melatonin by critically ill patients has also been shown to 
improve sleep duration and efficiency [88]. Additionally, melatonin has been shown to have 
remarkable antioxidant properties, preserves mitochondrial homeostasis, may protect against 
neurodegenerative processes, and combat free radical damage in the brain, therefore acting as a 
therapeutic agent in the treatment of cerebral oedema following TBI [89]. However, there appears 
to be no study that has specifically assessed the efficiency of melatonin to improve sleep and 
circadian rhythms in TBI patients.  
Cognitive behavioral therapy (CBT), including behavioral interventions such as Stimulus 
Control or Sleep Restriction (restriction of time in bed), has been shown to be efficient in 
improving the sleep efficiency, reducing sleep onset latency, and reducing the number of 
nocturnal awakenings, of mild to severe TBI patients suffering from insomnia  [90,91]. Strong 
evidence supports the use of CBT for primary insomnia in the general population, and this 
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intervention is being increasingly disseminated in populations with diverse health conditions by 
non-sleep specialists.  
When used in a small sample of patients with TBI (unspecified severity; n = 12; 2.2 ± 1.3 
years post-injury) and insomnia complaints, acupuncture has also been shown to have a 
beneficial effect on perception of insomnia severity and improved cognitive functioning, though 
acupuncture had no effect on sleep time, as measured by actigraphy  [92]. 
5.3. Interventions to improve hypersomnia 
Prior to treating hypersomnia, as with insomnia, the clinician should screen for medical 
and psychiatric conditions that may be associated with, or underlie hypersomnia (see Table 1). If 
sleep comorbidities (e.g. sleep breathing disorders (apnea), periodic limb movement in sleep, and 
narcolepsy) emerge, usual treatment for these conditions is recommended.  
Pharmacological treatments used in the management of hypersomnia include modafinil, 
amphetamine-based psychostimulants, methylphenidate-based psychostimulants, non-
psychostimulants, and amantadine, though studies on their effectiveness remain inconclusive 
with regards to post-TBI hypersomnia. For example, while Jha et al. [93] found no difference 
between modafinil and placebo, Kaiser et al. [94] observed a decrease in post-TBI daytime 
sleepiness, as measured by the ESS, the Maintenance of Wakefulness Test (MWT), and the 
amount of time spent awake according to actigraphy. Wiseman-Hakes et al. [57] reported that a 
methylphenidate-based psychostimulant was successful in improving day-time alertness and 
cognitive performance in a case study evaluation of an individual with severe TBI and post 
traumatic hypersomnia. 
6. Conclusions and study perspectives  
The goal of this review was to describe the current state of knowledge on sleep-wake 
disturbances and circadian rhythm alterations following TBI. We aimed to describe the possible 
causes of these alterations, and explore the pharmacologic and non-pharmacologic treatment 
options to treat them.  
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Sleep disturbances have been shown to exacerbate trauma related cognitive, 
communication and mood impairments, as well as pain, and compromise the recovery process 
[23,57].   Memory and new learning are often impaired following TBI of all severities, and the 
importance of sleep in hippocampal function, learning and the formation of memory in humans 
has been confirmed by imaging studies [93]. From a more general perspective, partial or chronic 
sleep restriction has negative repercussions for behavioral, cognitive, inflammatory, immune, 
cardiovascular, metabolic, and endocrine functions [96-100]. Taken together, these results 
suggest that acute and chronic sleep restriction and/or fragmentation in TBI survivors can hinder 
processes of physical, psychological and cognitive recovery, and lead to a reduction in learning 
capabilities, neural plasticity, and neurogenesis. Interestingly, Wiseman-Hakes et al. [23] 
reported functional, as well as clinically and statistically significant improvements in sustained 
and divided attention, working memory, speed of language processing and mood in response to 
individualized treatment of post-trauma onset sleep-wake disorders in adults (including sleep 
hygiene recommendations, pharmacological interventions and/or apnea treatment with follow-
up).  
Further studies should investigate how these sleep-wake and circadian disturbances 
originate and evolve, and whether measures can be taken to prevent them. Various treatment 
options should be further investigated, particularly in the acute phase where recovery is most 
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